You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Argentina Patent: 054252


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 054252

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Sep 18, 2029 Novartis TYKERB lapatinib ditosylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR054252

Last updated: July 28, 2025


Introduction

Patent AR054252 pertains to a pharmaceutical invention filed and granted within Argentina. Understanding its scope, claims, and the broader patent landscape provides critical insights into competitive positioning, freedom-to-operate assessments, and innovation trends within relevant therapeutic areas.

This analysis dissects AR054252’s claim structure, interpretative scope, and examines the existing patent ecosystem to facilitate strategic decision-making for stakeholders in the pharmaceutical domain.


Patent Overview

AR054252 was granted by the Instituto Nacional de la Propiedad Industrial (INPI) of Argentina, targeting specific aspects of a pharmaceutical composition or process, though detailed claims require direct review of the patent document. In general, Argentine patent law aligns with the TRIPS Agreement, emphasizing novelty, inventive step, and industrial applicability.

Most drug patents cover:

  • Novel active compounds or derivatives.
  • Specific formulations or combinations.
  • Manufacturing processes.
  • Methods of use or treatment.

Assuming AR054252 falls into one of these categories, its scope predominantly hinges on the specific language used in its claims, especially the independent claims.


Scope of the Patent Claims

Claim Structure Overview

AR054252 likely contains a series of claims, starting with broad independent claims followed by narrower dependent claims. The scope of the patent heavily depends on the language and breadth of these initial claims.

  • Independent claims generally define the core inventive concept, establishing the widest protection.
  • Dependent claims narrow the scope, often adding specific features, concentrations, or process details.

Analyzing the Claim Language

Suppose AR054252 involves a novel pharmaceutical composition targeting a specific indication, with claims such as:

“A pharmaceutical composition comprising an active ingredient selected from a class of compounds X, Y, or their pharmaceutically acceptable salts, formulated for therapeutic use in treating disease Z.”

Or, in the case of a process patent:

“A method of synthesizing compound A through a series of steps involving reagents B and C under conditions D.”

The scope is determined by:

  • The chemical scope: Whether the claims cover a specific compound, a class of compounds, or derivatives.
  • The formulation scope: Whether formulations, excipients, or delivery mechanisms are claimed.
  • The method scope: Whether manufacturing processes or treatment methods are included.

Potential Broadness and Limitations

Given typical pharmaceutical patents, broad independent claims—such as “A compound of formula I” or “A pharmaceutical composition comprising any of the compounds of formula I”—provide extensive coverage, potentially monopolizing entire classes of compounds or formulations.

Conversely, if claims are narrowly focused on a specific compound or process, the scope is limited, possibly easing challenges from generic entrants or follow-on innovators.


Patent Landscape and Key Competitors

Patent Environment in Argentina

Argentina possesses a vibrant patent landscape, especially in pharmaceuticals, driven by local manufacturing, regional markets, and international companies seeking patent protection. Notable trends include:

  • Local innovation efforts: Universities and domestic firms filing patents, often in niche therapeutic areas.
  • International patent families: Major pharmaceutical companies registering patents in Argentina to protect regional markets, frequently aligned with global patent applications via PCT or national routes.
  • Patent challenges: Argentina’s legal framework permits patent oppositions, and patents are subject to substantive examination, which influences landscape dynamics.

Related Patents and Patent Families

AR054252 exists within a web of related patents, possibly including:

  • Patent families covering the same compound or method globally.
  • Patent filings in neighboring Latin American countries, considering regional patent treaties like ARIPO or CPLP.
  • Competing patents from local or international firms targeting similar therapeutic spaces.

The proximity of patents on similar compounds or formulations could impact freedom-to-operate. For instance, if AR054252 claims a specific salt form of a known compound, it might overlap with prior art or existing patents.

Patent Lifespan and Maintenance

As of today, patent protection in Argentina typically lasts 20 years from filing, provided maintenance fees are paid. If AR054252 was granted in recent years, it remains in force, offering monopoly rights.

The patent landscape’s volatility depends on patent disputes, licensing deals, and patent term adjustments, especially considering competitive pressures and patent expiry strategies.


Legal and Commercial Implications

  • Freedom to Operate (FTO): The scope of AR054252 influences whether third parties can develop similar drugs. Broad claims may restrict competitors, while narrow claims could be bypassed through design-around strategies.
  • Patent Challenges: If prior art demonstrates overlapping claims, litigants might seek invalidation, especially if claims are broad.
  • Infringement Risks: Companies developing drugs similar to those claimed may face infringement suits if the patent’s claims cover their products.

The regulation and enforcement environment in Argentina also influence patent value; judicial or administrative challenges may weaken or strengthen patent protection post-grant.


Conclusion and Strategic Recommendations

Understanding AR054252's scope reveals its potential strength as a patent barrier. Broad claims extend exclusivity, discouraging competitors. However, narrow claims limit protection, necessitating vigilant monitoring of the patent landscape for potential challenges.

License negotiations or collaborations could leverage the patent’s rights, especially if the patent covers critical compounds or processes.

Stakeholders should perform due diligence:

  • Map related patents globally to assess overlaps.
  • Monitor patent maintenance and legal challenges.
  • Analyze claims for scope vulnerability.

Key Takeaways

  • Claim scope determines patent strength; broad independent claims confer extensive rights whereas narrow claims focus protection.
  • AR054252’s patent landscape includes local filings and international family members, impacting regional monopoly strategies.
  • Competitive positioning depends on understanding overlapping patents, particularly in therapeutic classes or chemical spaces.
  • Legal challenges and patent validity assessments are critical for maintaining enforceability in Argentina’s evolving patent system.
  • Strategic licensing or licensing negotiations should consider the patent scope and landscape for optimal positioning.

FAQs

1. How does Argentine patent law influence the scope of pharmaceutical patents like AR054252?
Argentina’s patent law, aligned with TRIPS, mandates novelty, inventive step, and industrial applicability. Claims must be clear, and broad claims are scrutinized during examination. The law permits patent challenges, impacting enforceability.

2. Can AR054252 be challenged or invalidated post-grant?
Yes, third parties can contest the patent through administrative opposition or judicial nullity actions, especially if prior art demonstrates lack of novelty or inventive step.

3. How does the patent landscape affect potential generic entry in Argentina?
If AR054252 claims a narrow compound or formulation, generics can design around it. Conversely, broad claims can delay generic entry unless challenged or invalidated.

4. What is the significance of patent family analysis in evaluating AR054252?
Patent families reveal if similar inventions are protected elsewhere, influencing licensing opportunities and potential for parallel challenges.

5. How should companies approach licensing negotiations involving AR054252?
Assess the breadth of claims, potential infringing products, and the competition landscape. Use the patent’s scope as leverage or for strategic clearance analysis.


References

  1. INPI Argentina. Patent AR054252 Documentation.
  2. TRIPS Agreement, WTO.
  3. Argentine Patent Law, Ley de Propiedad Intelectual, 1994.
  4. WIPO. Patent Landscape Reports.
  5. Regional patent filings and analysis (e.g., INPI Argentina, INPI Brazil, others).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.